[1] Mlynarsky L, Menachem Y, Shibolet O.  Treatment of hepatocellular carcinoma: Steps forward but still a long way to go[J]. World J Hepatol, 2015, 7(3): 566-574.   doi: 10.4254/wjh.v7.i3.566
[2] Cassinotto C, Aubé C, Dohan A.  Diagnosis of hepatocellular carcinoma: An update on international guidelines[J]. Diagn Interv Imaging, 2017, 98(5): 379-391.   doi: 10.1016/j.diii.2017.01.014
[3] 赵年, 李春华, 李德秀, 等.  MRI与CT多期动态增强扫描诊断肝硬化伴肝癌的效果比较[J]. 中国CT和MRI杂志, 2017, 15(5): 85-87, 99.   doi: 10.3969/j.issn.1672-5131.2017.05.026
Zhao N, Li CH, Li DX, et al.  Comparison of the Effects of MRI and CT Multi-phase Dynamic Contrast-enhanced Scan in the Diagnosis of Liver Cirrhosis with Liver Cancer[J]. Chin J CT and MRI, 2017, 15(5): 85-87, 99.   doi: 10.3969/j.issn.1672-5131.2017.05.026
[4] Choi SH, Byun JH, Lim YS, et al.  Diagnostic criteria for hepatocellular carcinoma ≤3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging[J]. J Hepatol, 2016, 64(5): 1099-1107.   doi: 10.1016/j.jhep.2016.01.018
[5] Yu MH, Kim JH, Yoon JH, et al.  Small (≤1cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging[J]. Radiology, 2014, 271(3): 748-760.   doi: 10.1148/radiol.14131996
[6] Kierans AS, Kang SK, Rosenkrantz AB.  The Diagnostic Performance of Dynamic Contrast-enhanced MR Imaging for Detection of Small Hepatocellular Carcinoma Measuring Up to 2 cm: A Meta-Analysis[J]. Radiology, 2016, 278(1): 82-94.   doi: 10.1148/radiol.2015150177
[7] Hanna RF, Miloushev VZ, Tang A, et al.  Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma[J]. Abdom Radiol (NY), 2016, 41(1): 71-90.   doi: 10.1007/s00261-015-0592-8
[8]

Li X, Li C, Wang R, et al. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis[J/OL]. PLoS One, 2015, 10(12): e0144247 [2018-07-05]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668097/pdf/pone.0144247.pdf. DOI: 10.1371/journal.pone.0144247.

[9] 徐安波, 丁朝鹏, 孟凡杰, 等.  磁共振动态增强和DWI在肝结节性病变与小肝癌诊断中的应用分析[J]. 医学影像学杂志, 2017, 27(5): 954-957.
Xu AB, Ding CP, Meng FJ, et al.  Application of dynamic contrast-enhanced MRI and DWI in the diagnosis of hepatic nodular lesions and small hepatocellular carcinoma[J]. J Med Imaging, 2017, 27(5): 954-957.
[10] Park SH, Chung YE, Hong HS, et al.  Detection of Hepatocellular Carcinoma: Comparison of Gadoxetic Acid-Enhanced MRI, Diffusion-Weighted Imaging, and Combined Interpretation at 3T MRI[J]. Korean Soc Radiol, 2013, 69(3): 213-222.   doi: 10.3348/jksr.2013.69.3.213
[11] Le MF, Durieux M, Bancel B, et al.  Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver[J]. Magn Reson Imaging, 2012, 30(5): 656-665.   doi: 10.1016/j.mri.2012.01.002
[12] Park MJ, Kim YK, Lee MW, et al.  Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns[J]. Radiology, 2012, 264(3): 761-770.   doi: 10.1148/radiol.12112517
[13] Di MM, Di MR, De Filippis G, et al.  Detection of small (≤2 cm) HCC in cirrhotic patients: added value of diffusion MR-imaging[J]. Abdom Imaging, 2013, 38(6): 1254-1262.   doi: 10.1007/s00261-013-0009-5
[14] Park MJ, Kim YK, Lee MH, et al.  Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (≤ 2.0 cm) in patients with hepatitis-induced liver cirrhosis[J]. Acta Radiol, 2013, 54(2): 127-136.   doi: 10.1258/ar.2012.120262
[15] Zhao XT, Li WX, Chai WM, et al.  Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?[J]. J Dig Dis, 2014, 15(3): 137-145.   doi: 10.1111/1751-2980.12119
[16] Chen ML, Zhang XY, Qi LP, et al.  Diffusion-weighted images (DWI) without ADC values in assessment of small focal nodules in cirrhotic liver[J]. Chin J Cancer Res, 2014, 26(1): 38-47.   doi: 10.3978/j.issn.1000-9604.2014.01.07
[17] Kwon HJ, Byun JH, Kim JY, et al.  Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images[J]. Abdom Imaging, 2015, 40(1): 64-75.   doi: 10.1007/s00261-014-0188-8
[18] Forner A, Vilana R, Ayuso C, et al.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma[J]. Hepatology, 2008, 47(1): 97-104.   doi: 10.1002/hep.21966
[19] Lim KS.  Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis[J]. Clin Radiol, 2014, 69(1): 1-10.   doi: 10.1016/j.crad.2013.07.022
[20] Piana G, Trinquart L, Meskine N, et al.  New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases[J]. J Hepatol, 2011, 55(1): 126-132.   doi: 10.1016/j.jhep.2010.10.023
[21] Nam SJ, Yu JS, Cho ES, et al.  High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions[J]. Clin Radiol, 2017, 72(3): 247-254.   doi: 10.1016/j.crad.2016.09.020
[22] Di PM, Briani C, Federici GF, et al.  Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules[J]. Clin Imaging, 2015, 39(3): 468-475.   doi: 10.1016/j.clinimag.2014.12.020
[23] Nakanishi M, Chuma M, Hige S, et al.  Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma[J]. Ann Surg Oncol, 2012, 19(4): 1302-1309.   doi: 10.1245/s10434-011-2066-8
[24] Gluskin JS, Chegai F, Monti S, et al.  Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment Response[J]. J Cancer, 2016, 7(11): 1565-1570.   doi: 10.7150/jca.14582
[25] Kim AY, Kim YK, Lee MW, et al.  Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis[J]. Acta Radiol, 2012, 53(8): 830-838.   doi: 10.1258/ar.2012.120099